SMAD3 c.658+4599T>C

Variant ID: 15-67467541-T-C

NM_005902.3(SMAD3):c.658+4599T>C

This variant was identified in 7 publications

View GRCh38 version.




Publications:


Establishment and characterization of a new mantle cell lymphoma cell line with a NOTCH2 mutation, Arbo.

Ejhaem
Safa, Firas F; Rasmussen, Terri T; Lobelle-Rich, Patricia P; Collier, Stephanie S; Milligan, Nicholas N; Schmeig, John J; Schmid, Janet J; Wiewiorowski, Carol C; Totaro, Denise D; Brown, Theresa C TC; Satyavarapu, Ishwarya I; Badoo, Melody M; Ungerleider, Nathan N; Flemington, Erik K EK; Safah, Hana H; Saba, Nakhle S NS
Publication Date: 2022-11

Variant appearance in text: rs12708492
PubMed Link: 36467812
Variant Present in the following documents:
  • JHA2-3-1326-s001.xlsx, sheet 1
View BVdb publication page



Genetic variants in the TGFβ-signaling pathway influence expression of miRNAs in colon and rectal normal mucosa and tumor tissue.

Oncotarget
Slattery, Martha L ML; Trivellas, Andromahi A; Pellatt, Andrew J AJ; Mullany, Lila E LE; Stevens, John R JR; Wolff, Roger K RK; Herrick, Jennifer S JS
Publication Date: 2017-03-07

Variant appearance in text: rs12708492
PubMed Link: 28061442
Variant Present in the following documents:
  • Main text
  • oncotarget-08-16765.pdf
View BVdb publication page



The influence of the CHIEF pathway on colorectal cancer-specific mortality.

Plos One
Slattery, Martha L ML; Lundgreen, Abbie A
Publication Date: 2014

Variant appearance in text: rs12708492
PubMed Link: 25541970
Variant Present in the following documents:
  • Main text
  • pone.0116169.pdf
View BVdb publication page



The influence of genetic ancestry and ethnicity on breast cancer survival associated with genetic variation in the TGF-β-signaling pathway: The Breast Cancer Health Disparities Study.

Cancer Causes & Control : Ccc
Slattery, Martha L ML; Lundgreen, Abbie A; Stern, Marianna C MC; Hines, Lisa L; Wolff, Roger K RK; Giuliano, Anna R AR; Baumgartner, Kathy B KB; John, Esther M EM
Publication Date: 2014-03

Variant appearance in text: rs12708492
PubMed Link: 24337772
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer.

Cancer
Slattery, Martha L ML; Lundgreen, Abbie A; Herrick, Jennifer S JS; Wolff, Roger K RK; Caan, Bette J BJ
Publication Date: 2011-09-15

Variant appearance in text: rs12708492
PubMed Link: 21365634
Variant Present in the following documents:
  • Main text
View BVdb publication page



Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-β-signaling pathway.

Carcinogenesis
Slattery, Martha L ML; Lundgreen, Abbie A; Herrick, Jennifer S JS; Caan, Bette J BJ; Potter, John D JD; Wolff, Roger K RK
Publication Date: 2011-03

Variant appearance in text: rs12708492
PubMed Link: 21088106
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genetic variation in the TGF-β signaling pathway and colon and rectal cancer risk.

Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology
Slattery, Martha L ML; Herrick, Jennifer S JS; Lundgreen, Abbie A; Wolff, Roger K RK
Publication Date: 2011-01

Variant appearance in text: rs12708492
PubMed Link: 21068203
Variant Present in the following documents:
  • Main text
View BVdb publication page